CRISPR Therapeutics AG Annual Payments to Acquire Property, Plant, and Equipment in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
CRISPR Therapeutics AG quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2015 to 2023.
  • CRISPR Therapeutics AG Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $721K, a 76.4% decline year-over-year.
  • CRISPR Therapeutics AG annual Payments to Acquire Property, Plant, and Equipment for 2023 was $9.47M, a 74.5% decline from 2022.
  • CRISPR Therapeutics AG annual Payments to Acquire Property, Plant, and Equipment for 2022 was $37.2M, a 54.5% decline from 2021.
  • CRISPR Therapeutics AG annual Payments to Acquire Property, Plant, and Equipment for 2021 was $81.7M, a 345% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.47M -$27.7M -74.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $37.2M -$44.5M -54.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $81.7M +$63.3M +345% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $18.4M +$11.7M +175% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $6.68M +$3.91M +141% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $2.77M -$5.04M -64.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
2017 $7.81M +$4.8M +159% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
2016 $3.02M +$1.86M +161% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $1.15M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.